scispace - formally typeset
H

Heba M. Refaat

Researcher at Alexandria University

Publications -  19
Citations -  211

Heba M. Refaat is an academic researcher from Alexandria University. The author has contributed to research in topics: Chemistry & Crystal structure. The author has an hindex of 7, co-authored 12 publications receiving 144 citations.

Papers
More filters
Journal ArticleDOI

Molecular docking, geometrical structure, potentiometric and thermodynamic studies of moxifloxacin and its metal complexes

TL;DR: Molecular docking was used to predict the binding between moxifloxacin (H2L) and the receptors of breast cancer mutant, prostate cancer mutant and crystal structure E. coli and S. aureus and it was found that the mox iflOxacin shows best interaction with 3hb5 receptor other than receptors.
Journal ArticleDOI

Metal complexes of moxifloxacin–imidazole mixed ligands: Characterization and biological studies

TL;DR: In this paper, mixed ligands complexes were evaluated for their antibacterial activity against two bacterial species, namely Staphylococcus aureus (S. aUREus), Escherichia coli (E. coli), and Condida albicans (C. coli).
Journal ArticleDOI

Chemical and biological evaluation of moxifloxacin-benzimidazole mixed ligands complexes: Anti-cancer and anti-oxidant activities

TL;DR: The novel mixed ligands complexes were evaluated for their biological activity against the bacterial species S. aureus and (E. coli) and the fungal species Aspergillus flavus and Candida albicans and found to possess better antibacterial and antifungal activities compared to the Moxifloxacin ligand.
Journal ArticleDOI

Structure evaluation of bismuth telluride (Bi2Te3) nanoparticles with enhanced Seebeck coefficient and low thermal conductivity

TL;DR: In this paper, Bismuth telluride (Bi2Te3) nanoparticles with different morphologies were synthesized using solvothermal process and the composition, the size and the micro-structure of the synthesized nanoparticles were analyzed.
Journal ArticleDOI

Characterization and biological activity of Pefloxacin–imidazole mixed ligands complexes

TL;DR: In this article, mixed ligands complexes were evaluated for their antibacterial activity against two bacterial species, namely Staphylococcus aureus (S.aureus), Escherichia coli (E. coli), and Candida albicans.